Abstract
In order to define more accurately the role of multidrug resistance (MDR)-related protein (mrp) gene in chronic lymphocytic leukemia (CLL), we addressed the question of its expression pattern in isolated peripheral blood B lymphocytes in seven healthy donors and 28 patients with CLL, with respect to some laboratory and clinical parameters of the disease. For this purpose, we used a semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), based on the coamplification of an internal standard not homologous to the DNA target to quantify the mrp transcription level in each studied sample. We report that the level of constitutive mrp gene's expression in peripheral blood lymphocytes is higher in CLL patients than in healthy controls. We found increased mrp gene expression levels in patients with higher white blood cells (WBC) and lymphocytes' counts as well as in more advanced disease stages according to Rai or Binet scale. Finally, mrp gene's expression was higher in patients with progressive CLL, especially in cases refractory to chemotherapy salvage. The results of the present study suggest that expression of mrp gene might be relevant in the pathogenesis of the MDR phenotype in CLL.
References
Apr 1, 1991·British Journal of Haematology·M MichieliP Tazzari
Oct 1, 1994·British Journal of Haematology·H BurgerG Stoter
Jan 19, 1994·Journal of the National Cancer Institute·M A BarrandP R Twentyman
Jun 18, 1994·Lancet·B J KussS A Whitmore
Apr 1, 1994·Leukemia & Lymphoma·J WallnerR Pirker
Apr 29, 1994·Biochemical Pharmacology·B W FutscherW S Dalton
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M A BarrandP R Twentyman
Jul 1, 1996·British Journal of Haematology·O LegrandJ P Marie
Jan 1, 1997·British Journal of Cancer·K NooterJ A Foekens
Jun 13, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K NooterG Stoter
Aug 29, 1998·British Journal of Haematology·M WebbP Craft
Oct 26, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y FukushimaM Nakamura
May 3, 2000·The Journal of Clinical Investigation·G F SullivanW N Hait
Citations
Mar 13, 2008·Cancer Chemotherapy and Pharmacology·Karina Lani SilvaRaquel Ciuvalschi Maia
Dec 26, 2006·Pflügers Archiv : European journal of physiology·Eva Bakos, László Homolya
May 10, 2008·Pharmacogenomics·Joseph MeletiadisThomas J Walsh
Aug 19, 2007·Leukemia & Lymphoma·Claire QuineyJean-Pierre Kolb
Mar 29, 2014·Drug Metabolism Reviews·Tereza Kunická, Pavel Souček
Jul 16, 2011·Cancer Treatment Reviews·J GongM Bebawy
Apr 25, 2014·Chemical Reviews·Gergely SzakácsAttilio Di Pietro
Jul 4, 2006·Physiological Reviews·Roger G DeeleySusan P C Cole
Aug 22, 2003·European Journal of Haematology·Y Richaud-PatinL Llorente